FSH Levels: Normal Range by Context, Cycle Phase and Menopause

At a Glance

FSH is made by the pituitary gland and signals the ovaries or testes. The gonads send feedback in return. When that feedback falls, the pituitary may release more FSH.

That makes FSH a feedback signal, not a universal reproductive-health score. Its meaning depends first on why it was measured: cycle and ovarian reserve, menopause, possible primary ovarian insufficiency (POI), or male reproductive evaluation.

If you remember only one thing

Context first, number second. An FSH value cannot be interpreted safely until you know the testing purpose, sex, menstrual or menopausal context, cycle day when relevant, medications, and the laboratory’s own reference interval.

Why one normal range does not work

Labcorp publishes different adult intervals for the same assay:

These are Labcorp assay intervals, not universal diagnostic cutoffs. mIU/mL and IU/L are numerically equivalent for FSH, so a value of 40 is the same figure in either unit — laboratories publish intervals in mIU/mL and guidelines state thresholds in IU/L, which is why both appear on this page. Pediatric intervals also change by age and sex and should come from the child’s own report.

A universal 1.5–12.4 band is unsafe: it is the Labcorp adult-male interval and would label the entire Labcorp postmenopausal interval high. A combined 1.5–134.8 range would create the opposite problem by hiding contextually important values.

The four questions FSH can be trying to answer

This is the page’s central distinction: the assay is the same, but the clinical question changes the reading.

Ovarian reserve: timing and estradiol matter

When FSH is used for ovarian-reserve testing, ASRM recommends measuring basal FSH together with estradiol in the early follicular phase, on cycle day 2, 3, or 4.

An elevated basal FSH is relatively specific for diminished ovarian reserve, but it is not sensitive. FSH also varies between and within cycles. A normal value therefore does not rule out diminished reserve.

Estradiol matters because an early rise can suppress an FSH value that otherwise might have been elevated. ASRM notes that early-follicular estradiol above roughly 60–80 pg/mL can help reveal this masking effect when FSH appears normal.

There is no universal “FSH above 10” rule that applies across assays and clinics. Use the testing laboratory’s threshold and the fertility clinic’s protocol. AMH and antral follicle count are often more sensitive measures, but no ovarian-reserve test by itself predicts whether someone will conceive naturally.

Menopause and perimenopause

FSH rises as ovarian feedback declines, but it fluctuates during the menopause transition. ACOG says most people do not need hormone testing to identify perimenopause; age, symptoms, and changes in periods are usually more useful. Testing may be offered when cycle changes occur before 45, especially before 40.

A postmenopausal FSH can be much higher than an early-cycle value without being pathologic. It should be read against a postmenopausal interval and in light of hormone therapy, which can lower FSH.

After hysterectomy with ovaries retained, the absence of periods makes staging harder. FSH may contribute, but a single value does not prove that the ovaries are active or inactive. If both ovaries were surgically removed, the clinical history already establishes the loss of ovarian function.

Primary ovarian insufficiency before age 40

Current ASRM/ESHRE guidance defines the diagnostic pattern as disordered menstrual cycles for at least four months plus FSH above 25 IU/L before age 40. FSH does not need to be timed to a specific cycle day for this purpose.

This is an important update: one elevated result can satisfy the biochemical criterion when the clinical picture fits. Repeat FSH after four to six weeks is recommended when there is diagnostic uncertainty, not automatically for every patient.

Pregnancy should be excluded. Hormonal contraception or other hormone therapy can conceal cycle disruption and lower FSH, so medication context is load-bearing. A low estradiol can support evidence of estrogen deficiency, but the guideline does not recommend diagnosing POI from estradiol alone.

FSH in men

FSH supports sperm production through the Sertoli cells; LH has a different role in testosterone production. High FSH can support impaired sperm production, especially when interpreted with semen findings and testicular examination. A normal FSH does not establish normal sperm production.

AUA/ASRM guidance does not recommend FSH and testosterone as the primary first-line test for male infertility. Semen analysis comes first; endocrine testing is added in appropriate clinical settings, including oligospermia. In azoospermia, FSH, testicular size, semen volume, and examination help distinguish impaired production from obstruction.

Low or inappropriately normal FSH and LH with low testosterone suggests reduced hypothalamic or pituitary signaling. Exogenous testosterone and anabolic steroids can suppress that signaling, so medication and supplement history matters.

How to read FSH with companion results

FSH and LH help describe a feedback pattern; neither one independently “localizes” a diagnosis. The LH-to-FSH ratio is not part of the current diagnostic criteria for PCOS.

Two people with the same result

Hypothetical example: two people each have an FSH of 40 IU/L.

One is postmenopausal and is not taking hormone therapy. Forty falls within Labcorp’s postmenopausal reference interval.

The other is 32, has had irregular cycles for more than four months, and is being evaluated for POI. Forty exceeds the current POI biochemical threshold, so the clinical pattern requires evaluation.

The number did not change. The testing context did.

What can change or complicate the result

Cycle timing. A midcycle rise should not be compared with an early-follicular reference interval.

Pulsatile release. Labcorp notes that interpreting one determination can be difficult because FSH secretion is pulsatile.

Hormonal medicines. Contraception, hormone therapy, fertility treatment, testosterone, and anabolic steroids can alter FSH.

Assay and laboratory differences. Reference intervals and ovarian-reserve thresholds vary by method.

Assay interference. Labcorp warns that certain antibodies or high-dose biotin can interfere with some immunoassays; follow the laboratory’s preparation instructions and discuss results that conflict with the clinical picture.

What this result cannot tell you

• It cannot supply one normal range for every patient.
• It cannot diagnose perimenopause from one number.
• It cannot measure egg quality or predict natural conception.
• It cannot measure sperm or establish male fertility.
• It cannot diagnose PCOS from an LH-to-FSH ratio.
• It cannot distinguish pituitary from hypothalamic causes by itself.

Common interpretation mistakes

Using the adult-male interval for everyone. This falsely flags expected postmenopausal results.

Treating a normal early-cycle FSH as proof of normal ovarian reserve. The test lacks that sensitivity.

Applying a day-3 cutoff to a sample drawn at another cycle phase. Timing changes the comparison.

Assuming every elevated value must be repeated before POI can be diagnosed. Current guidance requires repetition only when uncertainty remains.

Treating FSH as a fertility test in men. Semen analysis answers the primary question.

Questions your doctor may ask

• Why was FSH ordered?
• What age, menstrual or menopausal context, and cycle day apply?
• Are pregnancy or hormone medications relevant?
• Were LH, estradiol, testosterone, prolactin, AMH, or semen analysis also measured?
• Does the report’s own interval match the correct population and assay?

Read together with

Luteinizing hormone and the relevant sex steroid—estradiol or testosterone—help describe the feedback pattern. In ovarian-reserve testing, AMH and antral follicle count answer different questions. In male fertility evaluation, semen analysis is the central test. Prolactin may be relevant when gonadotropins and sex steroids suggest central suppression.

Clinical pearls

• A reference interval is not a diagnostic threshold. Labcorp’s phase-specific ranges and the POI threshold answer different questions.
• For ovarian reserve, a high basal FSH can be informative; a normal one cannot rule diminished reserve out.
• For typical perimenopause after 45, symptoms and cycle history usually matter more than hormone testing.
• One POI result may be enough when the current clinical criteria are met; repeat only if uncertainty remains.
• In men, FSH adds context to semen analysis—it does not replace it.

Clinical Takeaway

FSH is a feedback signal whose interpretation begins with the testing context. Establish whether the question is ovarian reserve, menopause, POI, or male reproductive evaluation; then use the correct timing, companion results, and laboratory interval.

In one sentence

Read FSH by testing context before interpreting whether it is high or low.

Bottom line

Do not compare an FSH result with a universal range. Identify the reason for testing, the relevant reproductive context, cycle timing when applicable, medications, and the report’s own interval. Then read FSH with the companion result that answers the clinical question—estradiol for ovarian feedback, or semen analysis and testosterone in male evaluation.